Jules Bordet Institute clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 106 studies whose lead sponsor is Jules Bordet Institute. 27 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 26, 2026.
Keep track of what changes. Save the Jules Bordet Institute studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Jules Bordet Institute leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 106. Browse all 106 →
- Biopsy-Resection Agreement of Peritoneal Histopathological Growth Patterns in Colorectal Peritoneal Metastases: A Prospective Observational Pilot StudyRecruitingNCT07474025
- Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)RecruitingNCT06150898Phase 2
- SCALp Cooling for pReventing aLopecia With nEw anTibody-drug ConjugatesNot yet recruitingNCT07474558Phase 2
- Medical Imaging to Re-evaluate Elacestrant Clinical UsageNot yet recruitingNCT07753954Phase 2
- AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.RecruitingNCT02102165Not applicable
- Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal CancerRecruitingNCT06052332Not applicable
- Randomized Clinical Investigation of Photobiomodulation (PBM) for the Management of Early Peripheral Neuropathy Related to Medical Oncologic TherapyNot yet recruitingNCT07681921Not applicable
- Immune Fitness in Older Patients With Relapsed and Refractory Multiple MyelomaRecruitingNCT07674498Not applicable
- Pregnancy Outcomes After Breast Cancer in Young Women With Germline Pathogenic Variants in Genes Other Than BRCANot yet recruitingNCT07591532
- Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.RecruitingNCT06523634Not applicable
- Flash Radiotherapy for Skin CancerNot yet recruitingNCT07455331Phase 2
- Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.RecruitingNCT07451483
- Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of LifeRecruitingNCT07143279Early Phase 1
- Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)RecruitingNCT06925984Not applicable
- LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.RecruitingNCT07370597
- A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid TumoursRecruitingNCT04109131Not applicable
- Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.RecruitingNCT07119294Not applicable
- The Role of the Imaging FAPI PET/CT in Exploring the Microenvironment of Colorectal Cancer Liver MetastasesRecruitingNCT07109440Not applicable
- PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.RecruitingNCT06059469Phase 2
- Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal CarcinomatosisRecruitingNCT06061874Not applicable
- Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint InhibitorsRecruitingNCT06107608Not applicable
- The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA)RecruitingNCT06867588Not applicable
- Evaluation of the RESTART Survival ProgrammeNot yet recruitingNCT06283511
- ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing StudyRecruitingNCT06227338Not applicable
- Assessment of DW-MRI Measures : Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy VolunteersNot yet recruitingNCT06458725Not applicable
- To Explore the Benefits of the MonaLisa Touch® System in Gynaecological Cancer Patients Treated by (Chemo)-RTRecruitingNCT05891470Not applicable
- Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapyRecruitingNCT04019548Phase 3
- Multidisciplinary Approach to FatigueTerminatedNCT05502224Not applicable
- Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:Active, not recruitingNCT03875573Phase 2
- Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBCActive, not recruitingNCT03616886Phase 1/2
- A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer PatientsCompletedNCT05487248Not applicable
- HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast CancerTerminatedNCT06595563Phase 2
- Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal MetastasesCompletedNCT06237582Not applicable
- Holistic Evaluation of Approaches to Long-term Health & SurvivorshipActive, not recruitingNCT07745205Not applicable
- Prophylactic Intervention for Dysgeusia in Head and Neck Cancer Patients Following Radio(Chemo)TherapyActive, not recruitingNCT07431346Not applicable
- Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal CancerActive, not recruitingNCT04503694Phase 2
- Management of Acute Complicated Diverticulitis: An Assessment of Current PracticesCompletedNCT07601958
- HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1CompletedNCT01565200Phase 2
- Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial)CompletedNCT03674424Phase 2
- A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients with Refractory and Relapsing Multiple Myeloma Expressing Somatostatin ReceptorsWithdrawnNCT06411301Phase 1
- Safety of Pregnancy in BRCA Mutated Breast Cancer PatientsCompletedNCT03673306
- De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 BlockadeTerminatedNCT04675827Phase 2
- Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)Active, not recruitingNCT04551495Phase 2
- Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck CancerActive, not recruitingNCT04452032Phase 2
- Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma PatientsCompletedNCT04379817Phase 2
- PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)CompletedNCT05880446Not applicable
- Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic FeaturesActive, not recruitingNCT05865756Not applicable
- Effects of Oxygen After Abdominal Oncological SurgeryCompletedNCT06321874Not applicable
- Multiorgan Metabolic Imaging Response Assessment of AbemaciclibCompletedNCT03339843Phase 2
- Inferior Epigastric Lymph Node in Colorectal CarcinosisCompletedNCT04966715Not applicable